Identity
Abbvie Spain, S.L.U.
| Year | Amount | Distribution |
|---|---|---|
| 2026* | €113.4M | |
| 2025 | €76.5M | |
| 2024 | €43.4M | |
| + regional platforms | ||
| 2023 | €22.0M | |
| 2022 | €22.6M | |
| 2021 | €8.4M | |
| 2020 | €4.8M | |
| 2019 | €104.6M | |
| 2018 | €2.4M | |
| 2017 | €14.6M | |
| 2016 | €0.8M | |
In figures
Volume
Between 2016 and 2026 it won 630 contracts worth €414M on its own, with 65 buyers. Its 5 joint-venture (UTE) contracts are shown separately.
Price
It has fewer than 3 comparable awards, too few to compute its median discount.
Competition
Since 2024, 7% of its comparable value was won with a discount and against other bidders. It was the only bidder in 91% of its contracts (2016–2026).
Renewals
46 contracts (€17.2M) come up for tender again in the next 24 months.
A UTE is a temporary joint venture: the contract is awarded to the UTE and each partner's share is not published. That is why these contracts are not added to Abbvie Spain, S.L.U.'s total, and under «Show UTEs» the amounts are the full value of each contract (100%), not Abbvie Spain, S.L.U.'s share.
Data up to 31 October 2026 · updated on 12 November 2026 · Source: official data, national and regional coverage
| UTE partners | Contracts | Total value (100 %) |
|---|
Its discounts
The discount at which it wins contested contracts, year by year.
Not enough comparable contracts to read this company’s pricing against the market.
2019–2024: median 23.0% · middle half between 16.6% and 29.7% · 6 awards
Discount on the tender budget, excluding VAT, on awards above the minor-contract threshold · Source: official data, national and regional coverage. Methodology →
Where it wins, and at what discount
In the report · these discounts, one by one
Each dot on the chart is an award. The report lists them all and groups them by buyer and by sector, next to the discounts of other companies with the same buyers.
By sector
Productos farmacéuticos
CPV 336
356 contracts · €234M
Full list: date, buyer, amount, budget, discount, bidders and a link to the official publication.
1 award at the tender price, left out of the discounts.
How it wins
Whether it wins with or without competition.
82% of the comparable value since 2024 (€3.59M of €4.36M) was won at the tender price and without other bidders. €458k (11%) was awarded with a discount and without other bidders.
Comparable: 23 awards with a published budget and bidder count (€4.36M of €233M awarded since 2024). Percentages of value; the figure next to «bidders» is the number of awards. Source: official data, national and regional coverage.
Between 2016 and 2026, 77.7% of the value was awarded through negotiated without publicity procedure (45.4% of contracts); followed by Based on a framework agreement (10.2%) and Open (6.5%).
Upcoming tenders and main buyers
When its contracts come back and who it sells to.
In the next 24 months 46 of its contracts come up for tender again, worth €17.2M.
| Expected end | Buyer | Value |
|---|---|---|
| 2026 | Gerencia de Servicio Sanitarios de Fuerteventura | €66.0k |
| 2026 | Gerencia de Servicio Sanitarios de Fuerteventura | €56.7k |
| 2026 | Gerencia de Servicio Sanitarios de Fuerteventura | €55.0k |
| 2026 | Gerencia de Servicio Sanitarios de Fuerteventura | €17.1k |
| 2026 | Gerencia de Servicio Sanitarios de Fuerteventura | €4.51k |
and 41 more in the next 24 months · the report includes them all
Expected end year from the published duration (no extensions). The report includes the month and the discount it won each one at.
| Buyer | Contracts | Value, € | Period |
|---|---|---|---|
| Gerencia Regional de Salud de Castilla y León | 7 | 107 M | 2019–2026 |
| OSAKIDETZA - Servicio Vasco de Salud -Director General | 14 | 73 M | 2025–2026 |
| Servicio Andaluz de Salud | 62 | 62 M | 2024–2026 |
| Gerencia de Servicio Sanitarios de Fuerteventura | 280 | 49 M | 2019–2026 |
| Gerencia de Atención Integrada de Cuenca | 16 | 23 M | 2017–2026 |
and 60 more buyers
Between 2016 and 2026, 100.0% of the value it won on its own is in Medical & pharmaceuticals (CPV 33, 616 contracts).
Recent awards
The evidence behind every insight in the report.
| Date | Contract | Buyer | Bidders | Value |
|---|---|---|---|---|
| 10/09/2026 | Acuerdo Marco para el suministro de medicamentos sin competencia para los hospitales del Servicio C… | Servicio Cántabro de Salud | 1 | €2.08k |
| 08/06/2026 | cpca 1º cbam abbvie spain,s.l. am 578/2025 | Servicio Andaluz de Salud | 1 | €1.03M |
| 03/06/2026 | suministro de medicamentos de uso humano tipo ii (exclusivos), lotes 259, 268 y 274, con destino al… | Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria | 2 | €98.6k |
| 27/04/2026 | Suministro Farmacéutico de los Principios Activos Adalimumab (20,40 y 80 ), Trastuzumab (150 y 420 … | Gerencia de Servicio Sanitarios de Fuerteventura | 1 | €3.01k |
| 20/04/2026 | CÓRDOBA 3ª Prórroga 1º CBAM ABBVIE SPAIN, S.L Acuerdo marco con una única empresa, por el que se fi… | Servicio Andaluz de Salud | 1 | €194k |